Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,026 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $517.97 | 10 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $360.16 | 4 | $0 (2024) |
| Johnson & Johnson Vision Care, Inc. | $231.69 | 4 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $219.62 | 6 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $196.01 | 5 | $0 (2021) |
| Allergan, Inc. | $117.91 | 2 | $0 (2021) |
| BIOTISSUE HOLDINGS INC. | $107.13 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $60.00 | 3 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $46.49 | 2 | $0 (2024) |
| Glaukos Corporation | $38.40 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $754.98 | 16 | Bausch & Lomb Americas Inc. ($265.31) |
| 2023 | $567.67 | 13 | Alcon Vision LLC ($357.76) |
| 2022 | $215.09 | 6 | Sun Pharmaceutical Industries Inc. ($137.28) |
| 2021 | $287.88 | 6 | Allergan, Inc. ($117.91) |
| 2020 | $142.54 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($142.54) |
| 2019 | $57.38 | 3 | Bausch & Lomb, a division of Bausch Health US, LLC ($32.55) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $14.80 | General |
| 10/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $124.68 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: EYE CARE | ||||||
| 10/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $14.80 | General |
| 09/16/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $77.53 | General |
| 09/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/31/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $34.38 | General |
| 07/16/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Ophthalmology | ||||||
| 05/09/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $91.80 | General |
| 05/08/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: SOLUTION/ DROPS | ||||||
| 04/25/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $14.67 | General |
| 03/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $124.15 | General |
| Category: Ophthalmology | ||||||
| 03/14/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/23/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Ophthalmology | ||||||
| 10/25/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Ophthalmology | ||||||
| 09/27/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: DRY EYE | ||||||
| 09/26/2023 | Alcon Vision LLC | Rocklatan (Drug), Simbrinza, Rhopressa | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: Ophthalmology | ||||||
| 09/13/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Ophthalmology | ||||||
| 08/18/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Ophthalmology | ||||||
| 06/30/2023 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Ophthalmology | ||||||
| 05/26/2023 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $116.41 | General |
| Category: Ophthalmology | ||||||
| 05/10/2023 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $94.85 | General |
| 05/10/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 495 | 575 | $111,349 | $35,062 |
| 2022 | 11 | 549 | 639 | $117,486 | $38,644 |
| 2021 | 10 | 383 | 428 | $85,664 | $30,111 |
| 2020 | 5 | 195 | 206 | $49,355 | $16,040 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 110 | $26,400 | $9,884 | 37.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 96 | 96 | $27,168 | $8,481 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 119 | $19,397 | $6,705 | 34.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 41 | 49 | $7,105 | $2,376 | 33.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 28 | 28 | $9,464 | $2,072 | 21.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 56 | 64 | $6,912 | $1,602 | 23.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 18 | 19 | $3,743 | $1,358 | 36.3% |
| 92134 | Imaging of retina | Office | 2023 | 40 | 48 | $4,512 | $1,351 | 29.9% |
| 92250 | Photography of the retina | Office | 2023 | 30 | 30 | $5,460 | $724.48 | 13.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $1,188 | $506.67 | 42.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 118 | 120 | $32,280 | $10,057 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 101 | $23,028 | $8,893 | 38.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 45 | 67 | $12,529 | $4,478 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 64 | $9,928 | $4,392 | 44.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 64 | 76 | $10,488 | $3,497 | 33.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 37 | 37 | $11,914 | $3,064 | 25.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 68 | 77 | $7,854 | $1,963 | 25.0% |
| 92134 | Imaging of retina | Office | 2022 | 32 | 37 | $3,293 | $1,000 | 30.4% |
| 92250 | Photography of the retina | Office | 2022 | 25 | 26 | $4,498 | $749.22 | 16.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 22 | 23 | $1,311 | $486.19 | 37.1% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 11 | 11 | $363.00 | $64.85 | 17.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 102 | 106 | $28,514 | $9,591 | 33.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 52 | $11,856 | $5,498 | 46.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 59 | 74 | $13,838 | $5,030 | 36.4% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 41 | 41 | $13,202 | $4,035 | 30.6% |
About Dr. Saad Ahmed, OD
Dr. Saad Ahmed, OD is a Optometrist healthcare provider based in South Kingstown, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2018. The National Provider Identifier (NPI) number assigned to this provider is 1336619550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Saad Ahmed, OD has received a total of $2,026 in payments from pharmaceutical and medical device companies, with $754.98 received in 2024. These payments were reported across 46 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,026).
As a Medicare-enrolled provider, Ahmed has provided services to 1,622 Medicare beneficiaries, totaling 1,848 services with total Medicare billing of $119,856. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist, Optometrist
- Location South Kingstown, RI
- Active Since 11/30/2018
- Last Updated 03/19/2024
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336619550
Products in Payments
- Rocklatan (Drug) $260.93
- MIEBO (Drug) $248.83
- Cequa (Drug) $194.79
- TOTAL30 (Device) $152.30
- ULTRA MULTIFOCAL TORIC (Device) $124.44
- DURYSTA (Drug) $115.42
- EYSUVIS (Drug) $104.74
- Acuvue (Device) $90.84
- XIIDRA (Drug) $76.48
- BIOTRUE ONE DAY (Device) $50.65
- XDEMVY (Drug) $46.49
- KXL System (Device) $38.40
- TYRVAYA (Drug) $34.12
- CEQUA (Drug) $24.83
- PREVNAR 20 (Biological) $24.02
- OXERVATE (Drug) $21.25
- INFUSE (Device) $20.92
- Multiple Brands Contact Lens (Device) $18.71
- ACTHAR (Biological) $18.07
- LUMIGAN (Drug) $16.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.